Ketobemidone, methadone and pethidine are non-competitive N-methyl-d-aspartate (NMDA) antagonists in the rat cortex and spinal cord
References (26)
- et al.
Pharmacology of excitatory amino acid receptors in the rat hemisected spinal cord
Eur. J. Pharmacol.
(1988) - et al.
Interactions between glutamatergic and monoaminergic systems within the basal ganglia - implications for schizophrenia and Parkinson's disease
Trends Neurosci.
(1990) - et al.
The combination of NMDA antagonism and morphine produces profound antinociception in the rat dorsal horn
Brain Res.
(1992) - et al.
Contribution of central neuroplasticity to pathological pain: review of clinical and experimental evidence
Pain
(1993) - et al.
Evidence for a role of the NMDA receptor in the frequency dependent potentiation of deep rat dorsal horn nociceptive neurones following c fibre stimulation
Neuropharmacology
(1987) - et al.
Identification of a novel NMDA receptor in rat cerebellum
Eur. J. Pharmacol. Mol. Pharmacol. Sect.
(1991) - et al.
The induction and maintenance of central sensitization is dependent on N-methyl-d-aspartic acid receptor activation: implications for post-injury pain hypersensitivity states
Pain
(1991) - et al.
The pharmacology of pain signalling
Curr. Opin. Neurobiol.
(1993) - Andersen, S., Ebert, B., Dickenson, A.H. and Kohn, M.,...
- et al.
Relationship between the inhibition constant (Ki) and the concentration of inhibitor, which causes 50 per cent inhibition (I50) of an enzymatic reaction
Biochem. Pharmacol.
(1973)
The opioid receptor binding profiles of ketobemidone and morphine
Pharmacol. Toxicol.
(1993)
Regional studies of catecholamines in the rat brain. I. Disposition of 3H-norepinephrine, 3Hdopamine and 3H-dopa in various regions of the brain
J. Neurochem.
(1966)
Glutamate transmission and toxicity in Alzheimer's disease
Prog. Neuro-Psychopharmacol. Biol. Psychiatry
(1988)
Cited by (224)
Anesthesia and analgesia in laboratory rodents
2023, Anesthesia and Analgesia in Laboratory AnimalsA hypothetical proposal to employ meperidine and tamoxifen in treatment of glioblastoma. Role of P-glycoprotein, ceramide and metabolic pathways
2022, Clinical Neurology and NeurosurgeryThe effects of morphine, methadone, and fentanyl on mitochondria: A live cell imaging study
2021, Brain Research BulletinBPR1M97, a dual mu opioid receptor/nociceptin-orphanin FQ peptide receptor agonist, produces potent antinociceptive effects with safer properties than morphine
2020, NeuropharmacologyCitation Excerpt :Thus, MOP-mediated β-arrestin recruitment may not be responsible for the side effects of BPR1M97, and the molecular mechanisms of BPR1M97 on gastrointestinal function should be evaluated by further research. Second, opioids such as morphine, naloxone, and methadone have been reported to activate nonopioid receptors, including the NMDA receptor (Ebert et al., 1995), TLR4 (Wang et al., 2012, 2016), and TREK-1 (Devilliers et al., 2013). Whether other nonopioid receptors are involved in BPR1M97 pharmacology should be determined.
Clinical benefits and risks of N-methyl-D-aspartate receptor antagonists to treat severe opioid use disorder: A systematic review
2020, Drug and Alcohol Dependence5.39 - Neuropathic Pain: Mechanisms, Clinical Aspects and Treatment Options
2020, The Senses: A Comprehensive Reference: Volume 1-7, Second Edition
Copyright © 1995 Published by Elsevier Ireland Ltd.